(NN) NN - Ratings and Ratios
Insurance, Banking, Pensions, Investments, Reinsurance
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 6.28% |
| Yield on Cost 5y | 13.75% |
| Yield CAGR 5y | 10.20% |
| Payout Consistency | 99.2% |
| Payout Ratio | 75.3% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 18.8% |
| Value at Risk 5%th | 27.1% |
| Relative Tail Risk | -12.32% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.58 |
| Alpha | 59.84 |
| CAGR/Max DD | 1.28 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.384 |
| Beta | 0.011 |
| Beta Downside | 0.109 |
| Drawdowns 3y | |
|---|---|
| Max DD | 21.81% |
| Mean DD | 5.37% |
| Median DD | 2.76% |
Description: NN NN January 02, 2026
NN Group N.V. (ticker NN) is a Dutch-based financial services group that offers a full suite of life and non-life insurance, banking, and pension products to individuals, SMEs, and corporate clients across the Netherlands and select international markets.
The firm operates through six segments: Netherlands Life, Netherlands Non-Life, Insurance Europe, Japan Life, Banking, and “Other” (including reinsurance and retirement services). Distribution channels comprise tied agents, bancassurance partners, brokers, and direct digital sales.
In 2023 the company reported net written premiums of roughly €16.5 bn, a combined ratio of 95 % in its core insurance business, and a return on equity of about 12 %, supporting a dividend yield near 5 %.
Key drivers of NN’s outlook include persistently low interest-rate environments that pressure investment income, rising inflation that can lift premium volumes, and demographic aging in Europe that fuels demand for pension and longevity products. Regulatory capital constraints under Solvency II also shape capital allocation decisions.
If you want a data-rich, quantitative deep-dive, consider checking the ValueRay platform’s analyst dashboards for additional metrics and scenario analyses.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income (1.56b TTM) > 0 and > 6% of Revenue (6% = 757.2m TTM) |
| FCFTA -0.00 (>2.0%) and ΔFCFTA -0.22pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 924.3% (prev 62.50%; Δ 861.8pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.00 (>3.0%) and CFO -401.0m <= Net Income 1.56b (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio -30.75 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (264.9m) change vs 12m ago -3.23% (target <= -2.0% for YES) |
| Gross Margin 100.0% (prev 77.85%; Δ 22.15pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 6.14% (prev 4.79%; Δ 1.35pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 3.94 (EBITDA TTM -968.0m / Interest Expense TTM 1.31b) >= 6 (WARN >= 3) |
ValueRay F-Score (Strict, 0-100) 49.62
| 1. Piotroski 3.50pt |
| 2. FCF Yield -1.88% |
| 3. FCF Margin -3.18% |
| 4. Debt/Equity 0.53 |
| 5. Debt/Ebitda -5.49 |
| 6. ROIC - WACC (= 5.61)% |
| 7. RoE 7.27% |
| 8. Rev. Trend -25.97% |
| 9. EPS Trend -45.49% |
What is the price of NN shares?
Over the past week, the price has changed by +0.82%, over one month by +2.09%, over three months by +12.36% and over the past year by +62.95%.
Is NN a buy, sell or hold?
What are the forecasts/targets for the NN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 67.5 | 1.3% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 89 | 33.7% |
NN Fundamental Data Overview January 17, 2026
P/E Trailing = 14.2991
P/E Forward = 8.3195
P/S = 1.2163
P/B = 0.8049
P/EG = 0.7164
Revenue TTM = 12.62b EUR
EBIT TTM = 5.16b EUR
EBITDA TTM = -968.0m EUR
Long Term Debt = 13.08b EUR (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 11.53b EUR (from shortLongTermDebtTotal, last fiscal year)
Net Debt = 5.32b EUR (from netDebt column, last quarter)
Enterprise Value = 21.35b EUR (17.58b + Debt 11.53b - CCE 7.76b)
Interest Coverage Ratio = 3.94 (Ebit TTM 5.16b / Interest Expense TTM 1.31b)
EV/FCF = -53.24x (Enterprise Value 21.35b / FCF TTM -401.0m)
FCF Yield = -1.88% (FCF TTM -401.0m / Enterprise Value 21.35b)
FCF Margin = -3.18% (FCF TTM -401.0m / Revenue TTM 12.62b)
Net Margin = 12.37% (Net Income TTM 1.56b / Revenue TTM 12.62b)
Gross Margin = 100.0% ((Revenue TTM 12.62b - Cost of Revenue TTM 0.0) / Revenue TTM)
Gross Margin QoQ = 100.0% (prev 100.0%)
Tobins Q-Ratio = 0.10 (Enterprise Value 21.35b / Total Assets 206.11b)
Interest Expense / Debt = 11.35% (Interest Expense 1.31b / Debt 11.53b)
Taxrate = 15.11% (84.0m / 556.0m)
NOPAT = 4.38b (EBIT 5.16b * (1 - 15.11%))
Current Ratio = unknown (Total Current Assets 112.98b / Total Current Liabilities -3.67b)
Debt / Equity = 0.53 (Debt 11.53b / totalStockholderEquity, last quarter 21.64b)
Debt / EBITDA = -5.49 (negative EBITDA) (Net Debt 5.32b / EBITDA -968.0m)
Debt / FCF = -13.26 (negative FCF - burning cash) (Net Debt 5.32b / FCF TTM -401.0m)
Total Stockholder Equity = 21.48b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.76% (Net Income 1.56b / Total Assets 206.11b)
RoE = 7.27% (Net Income TTM 1.56b / Total Stockholder Equity 21.48b)
RoCE = 14.93% (EBIT 5.16b / Capital Employed (Equity 21.48b + L.T.Debt 13.08b))
RoIC = 13.02% (NOPAT 4.38b / Invested Capital 33.64b)
WACC = 7.41% (E(17.58b)/V(29.11b) * Re(5.95%) + D(11.53b)/V(29.11b) * Rd(11.35%) * (1-Tc(0.15)))
Discount Rate = 5.95% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -3.23%
Fair Price DCF = unknown (Cash Flow -401.0m)
EPS Correlation: -45.49 | EPS CAGR: -49.89% | SUE: 0.0 | # QB: 0
Revenue Correlation: -25.97 | Revenue CAGR: -12.49% | SUE: -0.47 | # QB: 0
EPS next Year (2026-12-31): EPS=8.12 | Chg30d=+0.115 | Revisions Net=+0 | Growth EPS=+11.4% | Growth Revenue=+3.6%